Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
US biotech has been struggling to overcome fall in demand for coronavirus jabs
...On Monday, Disney said it was “hopeful Charter is ready to have more conversations that will restore access to its content to Spectrum customers as quickly as possible”....
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
...Two Humira biosimilars — from Organon in collaboration with Samsung Bioepis and Teva Pharmaceuticals working with Alvotech — earlier this year became the first to be granted interchangeable status by the...
Admonitions about staff trading in their employer’s shares may now need to be broadened
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...Similarly, more must be done by the global health community to ensure that a full spectrum of appropriate antibiotics is available, especially given the rise in antimicrobial resistance....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
US healthcare company is putting cash to work from spinning off its consumer health arm
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...Tim Harford (“The planet’s got 99 problems, but exponential growth isn’t one”, Spectrum, FT.com, January 13) may be right about economists’ understanding of mathematics....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...continue to be committed to the principle that we must have diverse viewpoints on our programs, and to that end, we will redouble our efforts to seek voices that represent different parts of the political spectrum...
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
US drugmaker is trying to chart its future without blockbuster Covid-19 products
...PIKs have always been at the risky end of the high yield spectrum, and MainFT has tended to strike a cautious tone around pretty much any firm that issues them, quoting one banker calling them a “Hail Mary...
Millions of Paxlovid pills have gone unused as tight controls restrict access
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
International Edition